Canaccord Genuity Defends Edwards Lifesciences (EW)
Tweet Send to a Friend
Canaccord Genuity maintained a Buy on Edwards Lifesciences (NYSE: EW) but cut its price target to $109.00 (from $123.00).
This article: 131 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This article: 131 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE